PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Usher Institute, The University of Edinburgh, Edinburgh, United Kingdom.\', \'Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.\', \'Population Data Science, Swansea University Medical School, Swansea, United Kingdom.\', \'School of Medicine, University of St. Andrews, St Andrews, United Kingdom.\', \'BREATHE-The Health Data Research Hub for Respiratory Health, University of Edinburgh, Edinburgh, United Kingdom.\', \'Queen\'s University Belfast, Belfast, United Kingdom.\', \'Public Health Agency, Belfast, United Kingdom.\', \'MRC/CSO Social & Public Health Sciences Unit, Glasgow, United Kingdom.\', \'Royal Infirmary of Edinburgh, NHS Lothian and Anaesthesia, Critical Care and Pain Medicine, The University of Edinburgh, Edinburgh, United Kingdom.\', \'Public Health Scotland, Glasgow, United Kingdom.\', \'Department of Mathematics and Statistics, University of Strathclyde, Glasgow, United Kingdom.\', \'Academic Primary Care, University of Aberdeen School of Medicine and Dentistry, Aberdeen, United Kingdom.\', \'School of Health, Wellington Faculty of Health, Victoria University of Wellington, New Zealand.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pmed.1003927
?:doi
?:hasPublicationType
?:journal
  • PLoS medicine
is ?:pmid of
?:pmid
?:pmid
  • 35192598
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.914
?:rankingScore_hIndex
  • 184
?:title
  • First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all